(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7.34%261.42B | 7.50%198.66B | 8.21%131.61B | 8.02%65.07B | 7.25%243.55B | 8.95%184.81B | 8.87%121.63B | 9.97%60.23B | 8.29%227.08B | 9.86%169.63B |
Operating income | 7.34%261.42B | 7.50%198.66B | 8.21%131.61B | 8.02%65.07B | 7.25%243.55B | 8.95%184.81B | 8.87%121.63B | 9.97%60.23B | 8.29%227.08B | 9.86%169.63B |
Cost of sales | -6.96%-180.72B | ---- | -8.19%-92.4B | ---- | -7.26%-168.96B | ---- | -8.43%-85.4B | ---- | -5.82%-157.53B | ---- |
Operating expenses | -6.96%-180.72B | -7.15%-137.64B | -8.19%-92.4B | -7.95%-46.39B | -7.26%-168.96B | -8.65%-128.46B | -8.43%-85.4B | -9.72%-42.98B | -5.82%-157.53B | -6.39%-118.24B |
Gross profit | 8.20%80.7B | 8.29%61.02B | 8.25%39.22B | 8.19%18.67B | 7.24%74.59B | 9.63%56.34B | 9.92%36.23B | 10.61%17.26B | 14.33%69.55B | 18.74%51.39B |
Selling expenses | -6.16%-40.98B | -6.06%-29.16B | -6.60%-18.77B | -4.74%-8.84B | -5.51%-38.6B | -5.33%-27.5B | -5.24%-17.61B | -7.73%-8.44B | -8.75%-36.58B | -11.75%-26.11B |
Administrative expenses | -6.71%-23.15B | -5.64%-8.17B | -6.15%-11.22B | -5.66%-2.32B | -7.06%-21.7B | -2.05%-7.74B | -13.29%-10.57B | -3.10%-2.19B | -13.06%-20.27B | -7.06%-7.58B |
Research and development expenses | ---- | -7.88%-8.05B | ---- | -10.26%-2.74B | ---- | -20.20%-7.46B | ---- | -20.13%-2.48B | ---- | -23.91%-6.2B |
Profit from asset sales | ---- | -165.42%-23.92M | ---- | -157.47%-690.23K | ---- | -82.39%36.56M | ---- | 110.35%1.2M | ---- | 494.71%207.58M |
Revaluation surplus | ---- | 116.19%44.13M | ---- | 427.87%38.83M | ---- | -785.48%-272.6M | ---- | -78.05%7.36M | ---- | 502.95%39.77M |
-Changes in the fair value of other assets | ---- | 116.19%44.13M | ---- | 427.87%38.83M | ---- | -785.48%-272.6M | ---- | -78.05%7.36M | ---- | 502.95%39.77M |
Impairment and provision | ---- | 1.38%-1.23B | ---- | -15.02%-401.29M | ---- | -43.07%-1.24B | ---- | -12.33%-348.89M | ---- | -3.10%-870.1M |
-Other impairment is provision | ---- | 1.38%-1.23B | ---- | -15.02%-401.29M | ---- | -43.07%-1.24B | ---- | -12.33%-348.89M | ---- | -3.10%-870.1M |
Operating interest expense | ---- | ---- | -149.01%-884M | ---- | ---- | ---- | 1.93%-355M | ---- | 45.95%-714M | ---- |
Special items of operating profit | 18.88%3.46B | 7.99%2.47B | 23.00%1.69B | 10.13%868.23M | 41.48%2.91B | -0.68%2.28B | 38.51%1.37B | 17.00%788.35M | -48.45%2.06B | -48.04%2.3B |
Operating profit | 16.45%20.04B | 16.10%16.1B | 10.62%10.04B | 13.12%5.04B | 22.47%17.21B | 9.95%13.87B | 20.49%9.07B | 16.54%4.45B | 17.64%14.05B | 15.76%12.62B |
Financing cost | -111.74%-2.11B | -82.88%106.93M | ---- | -49.46%-205.33M | ---997M | 310.41%624.76M | ---- | 19.67%-137.38M | ---- | 74.02%-296.92M |
Share of profits of associates | 12.96%1.79B | ---- | 15.15%1.08B | ---- | -16.21%1.58B | ---- | -0.64%937M | ---- | 16.54%1.89B | ---- |
Special items of earning before tax | ---- | 230.77%24.37M | ---- | -27.73%12.12M | ---- | -82.95%7.37M | ---- | 19.43%16.77M | ---- | 384.96%43.21M |
Earning before tax | 10.80%19.71B | 11.94%16.23B | 11.04%11.11B | 11.81%4.84B | 11.63%17.79B | 17.32%14.5B | 18.14%10.01B | 18.24%4.33B | 17.51%15.94B | 26.92%12.36B |
Tax | 2.55%-2.98B | -6.49%-2.97B | -3.45%-2.07B | -8.07%-814.54M | -13.05%-3.06B | -22.22%-2.79B | -31.06%-2B | -33.08%-753.69M | -21.14%-2.71B | -32.57%-2.28B |
After-tax profit from continuing operations | 13.57%16.73B | 13.24%13.26B | 12.94%9.05B | 12.60%4.03B | 11.34%14.73B | 16.21%11.71B | 15.30%8.01B | 15.53%3.58B | 16.80%13.23B | 25.71%10.08B |
Earning after tax | 13.57%16.73B | 13.24%13.26B | 12.94%9.05B | 12.60%4.03B | 11.34%14.73B | 16.21%11.71B | 15.30%8.01B | 15.53%3.58B | 16.80%13.23B | 25.71%10.08B |
Minority profit | 542.86%135M | 140.99%115.57M | 65.31%81M | 12.77%57.54M | -86.27%21M | -63.54%47.96M | -43.68%49M | 22.03%51.03M | -93.74%153M | -92.35%131.54M |
Profit attributable to shareholders | 12.81%16.6B | 12.71%13.15B | 12.61%8.96B | 12.60%3.97B | 12.49%14.71B | 17.26%11.67B | 16.05%7.96B | 15.44%3.53B | 47.24%13.08B | 57.90%9.95B |
Basic earnings per share | 13.29%1.79 | 12.80%1.41 | 14.12%0.97 | 13.16%0.43 | 12.06%1.58 | 16.82%1.25 | 14.86%0.85 | 15.15%0.38 | 5.22%1.41 | 11.69%1.07 |
Diluted earnings per share | 13.38%1.78 | 13.71%1.41 | 12.94%0.96 | 10.53%0.42 | 12.14%1.57 | 16.98%1.24 | 16.44%0.85 | 15.15%0.38 | 6.87%1.4 | 12.89%1.06 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Hwashin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hwashin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hwashin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data